Analyst Insights: Rudolph Technologies, Arena Pharmaceuticals, Kodiak, Mobile Mini, TIM Participacoes May 7th
Rudolph Technologies Inc. (NASDAQ:RTEC): After Rudolph Technologies dropped almost 15% following its results, Stifel Nicolaus thinks that the company’s overall business trends are accelerating. The firm believes that the company still has solid earnings leverage despite its increased operating expenses and it recommends buying the stock on its recent weakness.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): Jefferies remains cautious on the prospects for Arena’s obesity drug Lorqess and thinks the stock is not pricing in risk of a delay in approval. The firm keeps an Underperform rating on the stock with a $1 price target.
Kodiak Oil (AMEX:KOG): After Kodiak outlined its plan for meeting its year-end production guidance of 27,000 boe per day, Oppenheimer expects the company’s production volumes to accelerate sharply going forward, enabling it to meet its full-year guidance. The firm reiterates a $12 target and Outperform rating on the shares.
Mobile Mini, Inc. (NASDAQ:MINI): Oppenheimer reduced its target on Mobile Mini after the company reported lower than expected Q1 EPS. However, the firm maintains an Outperform rating on the stock.
TIM Participacoes S.A. (NYSE:TSU): BerCEO Luca Luciani resigned from all his positions at TIM Brasil and Telecom Italia. Bernstein does not think the departure indicates any larger accounting issues and that the problem is now one of momentum and uncertainty, creating an overhang for shares. The firm continues to rate shares an Outperform.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.